Refine by
Patient Breathing Articles & Analysis
31 news found
” Bill Heiden, Third Pole’s Chairman added, “This strategic investment in Third Pole Therapeutics is directly aligned with both organization’s mission to advance unique, disruptive, cost-effective solutions that improve outcomes in heart and lung-failure patients. It also provides validation that Third Pole’s technology represents the best in ...
Marianna University School of Medicine, Department of Respiratory Medicine, Kawasaki, Japan. “Many patients with advanced disease continue to struggle to breathe, making even simple daily tasks difficult. Having a treatment that can help patients breathe easier and live a better quality of life, without surgical ...
Only providing pain relief for two hours, many patients need repeat doses. Multiple injections into the spine are enough to make most opt for an epidural, which can even be administered using a dosage-capped patient-directed pain pump. ...
The researchers showed that Daxor’s BVA-100 was able to measure intravascular volume overload in heart failure patients – a key metric targeted to successfully manage heart failure. ...
When this happens fluid builds up in the lungs and patients have trouble breathing. Cone Health is the first in the country to use a new technology to measure the amount of fluid in the lungs in the inpatient hospital setting. ...
“This is very promising news for patients with advanced COPD. We know that treatment with Zephyr Valves can provide long-term improvements in lung function, breathing, and quality of life, but for patients with collateral ventilation, this minimally invasive treatment has not been available as an option,” explains Dr. ...
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. ...
Lungpacer is dedicated to natural breathing by developing minimally invasive technologies designed to help patients wean off mechanical ventilation and breathe on their own. ...
Additionally, there is persuasive human data from a compassionate use study in Europe, where three ALS patients were dosed with an intravenous version of BRAVYL for a month. In all three patients, decline in function was attenuated during and one month after fasudil infusions, in one patient breathing capacity increased during ...
“The VX1 system may help us tailor our procedures for each patient by more precisely pinpointing optimal ablation locations in real ...
IPF is a chronic and ultimately fatal disease that causes lung tissue to stiffen, leading to permanent lung scarring that makes it harder to breathe. As IPF progresses, patients often need oxygen and, in some cases, lung transplantation. ...
The aim of the REAL Study (Rho-kinasE for Als Study) is to assess the preliminary safety, efficacy, of BRAVYL in patients with ALS. The open label study will enroll 20 patients at up to 10 sites. ...
GEBT is an FDA-PMA approved, CE marked, Class III in-vitro diagnostic drug-medical device combination[i]product used for measuring the rate of solid phase gastric emptying and identifying delayed gastric emptying, a condition known as gastroparesis, in patients ages 18 years and older. This innovative breath test is non-invasive, orally administered, and ...
Aerogen, vibrating mesh nebuliser, is the ideal safe solution for your hospital being a powered device as required by the alert and needing no gas flow to drive it2–4 Available in 75+ countries and benefitting over 3 million COVID-19 patients in 2020 alone5, Aerogen’s closed-circuit system is instrumental in ensuring the safe and effective delivery of drugs to your ...
ByAerogen
Data highlights include: Confirmed shunt patency in all subjects at 3 months; Reduction in mean peak exercise pulmonary capillary wedge pressure (PCWP) by 20% (8 mmHg, p=.026) at 1 month; Reduction in mean NT-proBNP by 48% (582 pg/ml, p<.001) at 3 months; Increase in mean 6-minute walk distance by 50% (110 meters, p<.001) at 3 months; Increase in mean Kansas City Cardiomyopathy ...
“The ultimate goal in designing and engineering this respiratory solution was to improve clinical workflow efficiency and patient outcomes. We are essentially bringing the pulmonary lab right to the patient’s ...
Germany: University Rostock The workgroup for breath analysis “ROMBAT” has engaged in a study to employ breath analysis for COVID-19 screening in a real-life setting. ...
A breath-based gas exchange analysis using the AGM100® is easy to obtain for both practitioner and patient. The gas exchange analysis provided by the AGM100® requires the patient to simply breath into a mouthpiece and can be completed within two minutes. ...
The device has been designed to treat a wide range of patients with mild obstructive sleep apnea (OSA), in addition to primary snoring, by building endurance of the weak tongue and surrounding muscles known to be root causes of these conditions. Signifier has also focused on digital OSA therapy interfaces for patients and clinicians. An intuitive app for use ...
The MediPines AGM100® The MediPines Gas Exchange Monitor, AGM100®, is a respiratory monitoring system used to rapidly and non-invasively assess a patient’s respiratory status. It is the first portable monitoring system of its kind to integrate a comprehensive set of critical parameters and respiratory measurements analyzed from two-minute samples of ...